|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| OPERATING COSTS AND EXPENSES: | |||||
| Research and development expenses | |||||
| Professional fees (including stock-based compensation) | |||||
| General and administrative expenses | |||||
| Total operating expenses | |||||
| LOSS FROM OPERATIONS | |||||
| Unrealized loss on marketable securities | |||||
| Change in fair value of investments in joint ventures | |||||
| Interest income | |||||
| Dividend income | |||||
| OTHER (EXPENSES) INCOME, NET: | |||||
| Change in fair value of investment in joint venture | |||||
| Unrealized loss on crypto assets | |||||
| Dividend and interest income | |||||
| Total other income (expenses), net | |||||
| Total other (expenses) income, net | |||||
| NET LOSS | |||||
| Net Loss Attributable to Common Stockholders | |||||
| Other comprehensive income (loss): | |||||
| Foreign currency translation adjustment | |||||
| Total comprehensive loss | |||||
| NET LOSS PER COMMON SHARE: | |||||
| Basic | |||||
| Diluted | |||||
| WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING: | |||||
| Basic | |||||
| Diluted | |||||
Loading...